InxMed

About:

InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact.

Website: http://en.inxmed.com/

Top Investors: China Growth Capital | CGC, CBC Group, Grand Yangtze Capital, AIHC Capital, CMG-SDIC Capital Management

Description:

InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equipped with global-level top-notch know-how and efficient execution capabilities.